Dennie Jones, MD
University of Florida · University of New Mexico
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Dennie Jones, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:27 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT02920450 · Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC (UF-STO-LUNG-002)University of Florida · terminated · Non-Small Cell Lung Cancer · principal investigator
- Ph2NCT02920476 · TAS-102 in Previously Treated Unresectable or Metastatic Squamous Cell Lung Carcinoma (UF-STO-LUNG-003)University of Florida · completed · Squamous Cell Lung Carcinoma · principal investigator
- Ph1NCT00322751 · Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung CancerUniversity of New Mexico · completed · Lung Cancer · principal investigator
- Ph1NCT00251797 · A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS TumorsUniversity of New Mexico · completed · Brain and Nervous System, Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.